La resonancia magnética es ya una técnica diagnóstica utilizada de forma sistemática por los cardiólogos. Su demostrada utilidad y superioridad frente a otras técnicas de imagen en el estudio de la cardiopatía isquémica es, muy probablemente, la causa del gran interés que ha despertado en los últimos años. La cuantificación de la función ventricular global y segmentaria, de la perfusión miocárdica y de la viabilidad ha hecho que con una sola técnica pueda valorarse de forma completa al paciente con cardiopatía isquémica. Sin embargo, muchos aspectos básicos de la resonancia magnética siguen siendo desconocidos para una amplia mayoría. En este trabajo exponemos sus fundamentos, componentes del equipo, distintas secuencias, utilización de contrastes, seguridad y contraindicaciones.
Palabras clave
Resonancia magnética
Fundamentos
Secuencias
Contrastes
Seguridad
Este artículo solo puede leerse en
pdf
Bibliografía
[1.]
R. Damadian.
Tumor detection by nuclear magnetic resonance.
Science, (1971), 171 pp. 1151-1153
[2.]
M.R. Goldman, T.J. Brady, I.L. Pyket, C.T. Buro, F.S. Buonanno, J.P. Kistler, et al.
Quantification of experimental myocardial infarction using nuclear magnetic resonance imaging and paramagnetic ion contrast enhancement in excised canine hearts.
Circulation, (1982), 66 pp. 1012-1016
[3.]
J.A. San Román, P. Tejedor, E. Wu.
¿Por qué la resonancia magnética sigue infrautilizada en los pacientes con cardiopatía?.
Rev Esp Cardiol, (2004), 57 pp. 379-381
[4.]
F. Bloch.
Nuclear induction.
Physical Rev, (1946), 70 pp. 460-474
[5.]
F. Bloch, W.W. Hansen, M. Packard.
The nuclear induction experiment.
Physical Rev, (1946), 70 pp. 474-485
[6.]
D.A. Bluemke, J.L. Boxerman, E. Atalar, E.R. McVeigh.
Segmented k-space cine breath-hold cardiovascular MR imaging. Principles and technique.
AJR, (1997), 169 pp. 395-400
[7.]
J.C. Carr, O. Simonetti, J. Bundy, D. Li, S. Pereles, J.P. Finn.
Cine MR angiography of the heart with segmented true fast imaging with steady-state precession.
Radiology, (2001), 219 pp. 828-834
[8.]
V.S. Lee, D. Resnick, J.M. Bundy, O.P. Simonetti, P. Lee, J.C. Weinreb.
Cardiac function: MR evaluation in one breath hold with real-time true fast imaging with steady-state precession.
Radiology, (2002), 222 pp. 835-842
[9.]
C.C. Moore, E.R. McVeigh, E.A. Zerhouni.
Quantitative tagged magnetic resonance imaging of the normal human left ventricle.
Top Magn Reson Imaging, (2000), 11 pp. 359-371
[10.]
D.H. Szolar, H. Sakuma, C.B. Higgins.
Cardiovascular applications of magnetic resonance flow and velocity measurements.
J Magn Reson Imaging, (1996), 6 pp. 78-89
[11.]
N.M. Wilke, M. Jerosch-Herold, A. Zenovich, A.E. Stillman.
Magnetic resonance first-pass myocardial perfusion imaging: clinical validation and future applications.
J Magn Reson Imaging, (1999), 10 pp. 676-685
[12.]
J. Bogaert, A.M. Taylor, F. Van Kerkhove, S. Dymarkowski.
Use of Inversion Recovery Contrast-Enhanced MRI for Cardiac Imaging: Spectrum of Applications.
AJR, (2004), 182 pp. 609-615
[13.]
R. Soler, E. Rodríguez, C. Remuiñán, M.J. Bello, A. Díaz.
Magnetic Resonance Imaging of Primary Cardiomyopathies.
J Comput Assist Tomogr, (2003), 27 pp. 724-734
[14.]
M.T. Alley, R.Y. Shifrin, N.J. Pelc, R.J. Herfkens.
Ultrafast contrast-enhanced three-dimensional MR angiography: state of the art.
Radiographics, (1998), 18 pp. 273-285
[15.]
D.H. Lee.
Mechanisms of contrast enhancement in magnetic resonance imaging.
Canadian Association of Radiologist Journal, (1991), 42 pp. 6-12
[16.]
M.R. Prince, C. Arnoldus, J.K. Frisoli.
Nephrotoxicity of high-dose gadolinium compared with iodinated contrast.
JMRI, (1996), 1 pp. 162-166
[17.]
K.L. Nelson, L.M. Gifford, C. Lauber-Huber, C.A. Gross, T.A. Lasser.
Clinical safety of gadopentetate dimeglumine.
Radiology, (1995), 196 pp. 439-443
[18.]
J. Hug, E. Nagel, A. Bornstedt, B. Schnackenburg, H. Oswald, E. Fleck.
Coronary arterial stents: safety and artifacts during MR imaging.
Radiology, (2000), 216 pp. 781-787
[19.]
O. Strohm, D. Kivelitz, W. Groiss, J. Schulz-Menger, X. Liu, B. Hamm, et al.
Safety of implantable coronary stents during 1H-magneteic resonance imaging at 1.0 and 1.5 T.
J Cardiovasc Magn Reson, (1999), 1 pp. 239-245
[20.]
M.G. Fiedrich, O. Strohm, D. Kivelitz, W. Groiss, A. Wagner, J. Schulz-Menger, et al.
Behaviour of implantable coronary stents during magnetic resonance imaging.
Int J Cardiovasc Intervent, (1999), 2 pp. 217-222
[21.]
T.C. Gerber, P. Fasseas, R.J. Lennon, V.U. Valeti, C.P. Wood, J.F. Breen, et al.
Clinical safety of magnetic resonance imaging early after coronary artery stent placement.
J Am Coll Cardiol, (2003), 42 pp. 1295-1298
[22.]
A.P. Schroeder, K. Houlind, E.M. Pedersen, L. Thuesen, T.T. Nielsen, H. Egeblad.
Magnetic resonance imaging seems safe in patients with intracoronary stents.
J Cardiovasc Magn Reson, (2000), 2 pp. 43-49
[23.]
C.M. Kramer, W.J. Rogers, D.L. Pakstis.
Absence of adverse outcomes after magnetic resonance imaging early after stent placement for acute myocardial infarction: a preliminary study.
J Cardiovasc Magn Reson, (2000), 2 pp. 257-261
[24.]
C.X. Kim, E. Wu, D.C. Lee, D.J. Davidson, R. Bonow, M. Ricciardi.
Cardiac MRI within one week of coronary stent implantation is safe.
J Cardiovasc Magn Reson, (2005), 7 pp. 301
[25.]
E. Kanal, J.P. Borgstede, A.J. Barkovich, C. Bell, W.G. Bradley, S. Etheridge, et al.
American College of Radiology white paper on MR safety: 2004 update and revisions.
Am J Roentegenol, (2004), 182 pp. 1111-1113
[26.]
W. Irnich, B. Irnich, C. Bartsch, A. Stertmann, H. Gufler, G. Weiler.
Do we need pacemakers resistant to magnetic resonance imaging?.
Europace, (2005), 7 pp. 353-365
[27.]
Y. Sakakibara, T. Mitsui.
Concerns about sources of electromagnetic interference in patients with pacemakers.
Jpn Heart J, (1999), 40 pp. 737-743
[28.]
A. Roguin, M.M. Zviman, G.R. Meininger, E.R. Rodrigues, T.M. Dickfeld, D.A. Bluemke, et al.
Modern pacemaker and implantable cardioverter/defibrillator systems can be magnetic resonance imaging safe: in vitro and in vivo assessment of safety and function at 1.5 T.
Circulation, (2004), 110 pp. 475-482
[29.]
R. Luechinger, V.A. Zeijlemaker, E.M. Pedersen, P. Mortensen, E. Falk, F. Duru, et al.
In vivo heating of pacemaker leads during magnetic resonance imaging.
Eur Heart J, (2005), 26 pp. 376-383
[30.]
E.T. Martin.
Can cardiac pacemakers and magnetic resonance imaging systems co-exist?.
Eur Heart J, (2005), 26 pp. 325-327
[31.]
O.G. Anfinsen, R.F. Berntsen, H. AAss, E. Kongsgaard, J.P. Amlie.
Implantable cardioverter defibrillator dysfunction during and after magnetic resonance imaging.
Pacing Clin Electrophysiol, (2002), 25 pp. 1400-1402
[32.]
J.R. Gimbel, E. Kanal, K.M. Schwartz, B.L. Wilkoff.
Outcome of magnetic resonance imaging (MRI) in selected patients with implantable cardioverter defibrillators (ICDs).
Pacing Clin Electrophysiol, (2005), 28 pp. 270-273
Trabajo parcialmente financiado por la Red Cooperativa de Investigación Cardiovascular del Instituto de Salud Carlos III.
Copyright ©
2006. Sociedad Española de Cardiología